SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Anthony James Hatswell · Study

Home/Author

Anthony James Hatswell

4 works· latest 2019· 2 institutionscluster: provisionalORCID 0000-0003-1129-326X

h-index4

i104

Citations409

Works here4

14

16

18

19

Most cited in this library

Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–20142016 · 186 citations
Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models2018 · 114 citations
Transparency in Decision Modelling: What, Why, Who and How?2019 · 61 citations
Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death2014 · 48 citations

Works

4 shown

Transparency in Decision Modelling: What, Why, Who and How?

PharmacoEconomics·2019·12 authors·review·Open access

61citations

Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models

PharmacoEconomics·2018·4 authors

114citations

Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014

BMJ Open·2016·5 authors·Open access

186citations

Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death

Health and Quality of Life Outcomes·2014·6 authors·Open access

48citations